Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) Read more about Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study Read more about IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection Read more about Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma Read more about Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis Read more about Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis
Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics. Read more about Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Read more about Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Read more about A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
Virtual Colonoscopy Using Omnipaque as a Contrast Agent Read more about Virtual Colonoscopy Using Omnipaque as a Contrast Agent
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies Read more about Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies